• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体内,α-1-酸性糖蛋白会降低哌唑嗪的药理活性。

Pharmacologic activity of prazosin is decreased by alpha-1-acid glycoprotein in vivo.

作者信息

Chiang J, Oie S

机构信息

Department of Pharmacy, School of Pharmacy, University of California, San Francisco.

出版信息

J Pharmacol Exp Ther. 1990 Jul;254(1):324-9.

PMID:2164099
Abstract

The pharmacologic response to drugs is generally assumed to be related to the unbound concentration of the active species. This study, however, reports that the alpha-1 adrenergic blocking activity of prazosin is lower in the presence than in the absence of the plasma protein alpha-1-acid glycoprotein (AAG), at the same unbound concentrations. This phenomenon suggests that plasma proteins can modify the activity of drugs by mechanisms other than those reflected by changes in the unbound fraction values. The pharmacodynamic activity (percentage of decrease in systolic blood pressure) of prazosin was studied in control rats and in rats that were administered 40 mg/kg of human AAG. The effect vs. log unbound concentration relationships were right-shifted in the presence of AAG both after intravenous bolus doses (160 micrograms/kg) and during intravenous infusion (0.6-2.4 micrograms/min/kg), i.e., AAG decreased the activity of unbound prazosin. The Emax and EC50 (mean +/- S.E.) values for unbound prazosin in control animals in the intravenous bolus study were 33.4 +/- 2.6% of the control blood pressure (zero time) and 6.2 +/- 1.4 ng/ml, respectively; and in AAG-treated animals 37.8 +/- 6.0% of the control blood pressure and 18.9 +/- 6.1 ng/ml, respectively. The EC50 value was statistically significantly increased in the presence of AAG (t = 4.97, P less than .001) whereas no difference was seen in the Emax value (t = 1.65, P greater than .1). The possible underlying mechanism(s) of the effect of AAG is discussed.

摘要

一般认为,药物的药理反应与活性成分的游离浓度有关。然而,本研究报告称,在相同的游离浓度下,哌唑嗪的α1肾上腺素能阻断活性在有血浆蛋白α1酸性糖蛋白(AAG)存在时比不存在时要低。这一现象表明,血浆蛋白可通过游离分数值变化所反映机制以外的其他机制来改变药物活性。在对照大鼠和给予40mg/kg人AAG的大鼠中研究了哌唑嗪的药效学活性(收缩压降低百分比)。无论是静脉推注剂量(160μg/kg)后还是静脉输注期间(0.6 - 2.4μg/min/kg),在有AAG存在的情况下,效应与对数游离浓度的关系曲线均右移,即AAG降低了游离哌唑嗪的活性。在静脉推注研究中,对照动物中游离哌唑嗪的Emax和EC50(平均值±标准误)值分别为对照血压(零时间)的33.4±2.6%和6.2±1.4ng/ml;在接受AAG治疗的动物中分别为对照血压的37.8±6.0%和18.9±6.1ng/ml。在有AAG存在的情况下,EC50值有统计学显著升高(t = 4.97,P<0.001),而Emax值未见差异(t = 1.65,P>0.1)。文中讨论了AAG作用可能的潜在机制。

相似文献

1
Pharmacologic activity of prazosin is decreased by alpha-1-acid glycoprotein in vivo.在体内,α-1-酸性糖蛋白会降低哌唑嗪的药理活性。
J Pharmacol Exp Ther. 1990 Jul;254(1):324-9.
2
Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.
J Pharmacol Exp Ther. 1987 Jun;241(3):934-8.
3
The effect of alpha 1-acid glycoprotein on the pharmacological activity of alpha 1-adrenergic antagonists in rabbit aortic strips.α1-酸性糖蛋白对兔主动脉条中α1-肾上腺素能拮抗剂药理活性的影响。
J Pharm Pharmacol. 1991 Aug;43(8):540-7. doi: 10.1111/j.2042-7158.1991.tb03533.x.
4
Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.高剂量α-1-酸性糖蛋白对大鼠地昔帕明毒性的影响。
J Pharmacol Exp Ther. 1988 Sep;246(3):1061-6.
5
Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.白蛋白和α-1酸性糖蛋白对离体灌注大鼠肝脏中哌唑嗪和安替比林消除的影响。
J Pharmacol Exp Ther. 1985 Sep;234(3):636-40.
6
Decreased elimination of drug in the presence of alpha-1-acid glycoprotein is related to a reduced hepatocyte uptake.在存在α-1-酸性糖蛋白的情况下药物消除减少与肝细胞摄取减少有关。
J Pharmacol Exp Ther. 1994 Jun;269(3):1176-81.
7
Effect of an alkylating analog of prazosin on alpha-1 adrenoceptor subtypes and arterial blood pressure.哌唑嗪烷基化类似物对α-1肾上腺素能受体亚型及动脉血压的影响。
J Pharmacol Exp Ther. 1989 Dec;251(3):878-83.
8
Pharmacological characterization of alpha adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine.鞘内注射可乐定的抗伤害感受和心血管效应中涉及的α肾上腺素能受体的药理学特性
J Pharmacol Exp Ther. 1989 Oct;251(1):27-38.
9
Effects of alpha-1-acid glycoprotein on the cardiovascular toxicity of nortriptyline in a swine model.α-1-酸性糖蛋白对猪模型中去甲替林心血管毒性的影响。
Vet Hum Toxicol. 1991 Jun;33(3):226-30.
10
Effect of altered plasma protein binding on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery: role of alpha-1-acid glycoprotein.血浆蛋白结合改变对大鼠术后普萘洛尔药代动力学和药效学的影响:α-1-酸性糖蛋白的作用
J Pharmacol Exp Ther. 1985 Nov;235(2):513-20.

引用本文的文献

1
Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.在α1-酸性糖蛋白水平升高的大鼠中,来立司琼的处置和效应发生改变。
Pharm Res. 2001 Jun;18(6):838-45. doi: 10.1023/a:1011096714860.